About Tymora Analytical
Tymora Analytical is a company based in Lafayette (United States) founded in 2010. Tymora Analytical offers products and services including pIMAGO Phosphoprotein Detection, PolyMAC Phosphopeptide Enrichment Kit, EVtrap Technology, Plasma Proteomics Service, and Urine Proteomics Service. Tymora Analytical operates in a competitive market with competitors including ArcherDX, Third Wave Technologies, Diagnostic Hybrids, Gen-Probe and KiOmed Pharma, among others.
- Headquarter Lafayette, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$290 K (USD), Grant
Sep 01, 2022
-
Investors
NIH
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tymora Analytical
Tymora Analytical offers a comprehensive portfolio of products and services, including pIMAGO Phosphoprotein Detection, PolyMAC Phosphopeptide Enrichment Kit, EVtrap Technology, Plasma Proteomics Service, and Urine Proteomics Service.
Kit for detecting phosphoproteins on Western Blot or microplate.
Kit for enriching phosphopeptides from biological samples.
Technology for recovering and purifying extracellular vesicles.
Service for analyzing proteins in plasma samples.
Service for proteomics analysis of urine samples.
Funding Insights of Tymora Analytical
Investors in Tymora Analytical
Tymora Analytical has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and National Cancer Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Cancer research is conducted and supported by the institute.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Tymora Analytical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tymora Analytical
Investment portfolio details for Tymora Analytical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tymora Analytical
Detailed financials for Tymora Analytical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tymora Analytical Comparisons
Peer comparison for Tymora Analytical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tymora Analytical
Tymora Analytical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Third Wave Technologies, Diagnostic Hybrids, Gen-Probe and KiOmed Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Molecular diagnostic devices and reagents are developed and marketed.
|
|
| Locked | Locked | Locked |
Molecular diagnostic kits for infectious diseases are developed and manufactured.
|
|
| Locked | Locked | Locked |
Provides clinical diagnostics, blood screening, and research products.
|
|
| Locked | Locked | Locked |
Bio-polymer chitosan products are developed for medical uses.
|
|
| Locked | Locked | Locked |
Microfluidic technology is developed for diagnostic and research applications.
|
Detailed competitors of Tymora Analytical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tymora Analytical
Complete news archive for Tymora Analytical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tymora Analytical
Tymora Analytical was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Tymora Analytical is headquartered in Lafayette, United States. It is registered at Lafayette, Louisiana, United States.
Tymora Analytical was founded in 2010 and is headquartered in Lafayette, United States. Operations focus on the biotechnology sector, where laboratory technologies for protein analysis are provided. Key products include pIMAGO, which utilizes water-soluble nanopolymers to target phosphate groups with detection aids like biotin and fluorophores, and PolyMAC, a metal-ion functionalized nanopolymer designed for phosphopeptide recognition. These tools support research in protein phosphorylation and related fields.
Tymora Analytical's top competitors include ArcherDX, KiOmed Pharma and Third Wave Technologies.
Tymora Analytical offers pIMAGO Phosphoprotein Detection, PolyMAC Phosphopeptide Enrichment Kit, EVtrap Technology, Plasma Proteomics Service, and Urine Proteomics Service.
Tymora Analytical has 4 investors. Key investors include NIH, HHS, National Cancer Institute, and National Science Foundation.